Overview

Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain

Status:
Completed
Trial end date:
2017-11-03
Target enrollment:
0
Participant gender:
Female
Summary
This is a randomized controlled trial to test whether the use of liposomal bupivacaine at the time of cesarean delivery may decrease post-operative pain scores.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Bupivacaine
Criteria
Inclusion Criteria:

1. Scheduled cesarean delivery via Pfannenstiel incision;

2. Planned neuraxial anesthetic with intrathecal morphine and fentanyl administration.

Exclusion Criteria:

1. Current or prior use of methadone, buprenorphine, or other opioids before cesarean
delivery;

2. Contraindication to neuraxial anesthetic;

3. Allergy to local anesthetic;

4. Planned general anesthetic.